This inventor holds 12 USPTO granted patents and 15 published patent applications, plus 1 CIPO patent and 8 EPO patents. Top assignees: Annexin Pharmaceuticals Ab, Athera Biotechnologies Ab, Medirista Biotechnologies Ab. Active years: 2010-2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Nacka, SE (2010 - 2011)
- Stockholm, SE (2014 - 2023)
Company Filing History:
6 out of 8 
5 out of 8 
1 out of 1 Years Active: 2010-2023
Title: Innovations by Johan Frostegard
Introduction
Johan Frostegard is a notable inventor based in Stockholm, Sweden. He has made significant contributions to the field of vascular medicine, particularly through his innovative approaches to treating vascular diseases. With a total of 12 patents to his name, Frostegard's work has the potential to impact many patients suffering from various vascular conditions.
Latest Patents
Frostegard's latest patents include several methods and compositions aimed at treating restenosis and other vascular diseases. One of his key inventions is a method for treating restenosis using Annexin A5, which involves administering a therapeutically effective amount of Annexin A5 or its functional analogs to patients in need. Another patent focuses on a method for treating stenosis, which combines an intervention with the administration of Annexin A5. Additionally, he has developed a pharmaceutical composition for the prophylaxis or treatment of restenosis and a drug-eluting stent that incorporates Annexin A5. His work also encompasses compounds and methods for treating vascular dysfunction, which can alleviate ischemic pain and address various vascular diseases.
Career Highlights
Throughout his career, Johan Frostegard has worked with prominent companies in the biotechnology sector, including Annexin Pharmaceuticals AB and Athera Biotechnologies AB. His innovative research and development efforts have positioned him as a key figure in the advancement of treatments for vascular diseases.
Collaborations
Frostegard has collaborated with notable professionals in his field, including Knut Pettersson and Ola Camber. These partnerships have contributed to the success of his research and the development of his patented inventions.
Conclusion
Johan Frostegard's contributions to vascular medicine through his innovative patents demonstrate his commitment to improving patient outcomes. His work continues to pave the way for advancements in the treatment of vascular diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile